Procedure mininvasive e transcatetere per i pazienti più fragili: le novità discusse al MICS 2026

Innovation is profoundly transforming cardiology and cardiac surgery. Artificial intelligence, robotics, precision medicine, and transcatheter technologies are now enabling increasingly personalized care and minimally invasive approaches to once-surgical procedures. But technology alone, according to Giuseppe Speziale (Santa Maria Hospital in Bari and President of MICS), is not enough. For Speziale, interviewed at the MICS - Minimally Invasive and Catheter Solutions 2026 Congress, the challenge is to build an ecosystem capable of integrating professionals, organizations, and care models, ensuring continuity of care and sustainability. Questions 0:00 Introduction 0:11 What innovations are currently most transforming the clinical decision-making process in the treatment of cardiovascular diseases? 1:28 What are the main factors currently guiding therapeutic choice in valvular diseases? 2:32 What is the main message that MICS 2026 wants to convey to the international scientific community? Follow Cardioinfo: Website: https://bit.ly/3fzgryk X: https://bit.ly/2AGPpqj Linkedin: https://bit.ly/2UVRCET